Citations

Showing 10 of 108094 citations.

Marine Invertebrate Natural Products that Target Microtubules
Miller, John H. , Field, Jessica J. , Owen, Jeremy G. , Singh, A. Jonathan , Northcote, Peter T. , Kanakkanthara, Arun , Singh, A Jonathan , Northcote, Peter T

Mayo Clinic

Journal of Natural Products | February 12, 2018 | Volume: 81 | Issue: 3 | Pages: 691-702

10.1021/acs.jnatprod.7b00964 | PMID 29431439 Get It

Technics for the Isolation of Fungi from Tissues Obtained at Operation and Necropsy
Weed, Lyle A.

Mayo Clinic

American Journal of Clinical Pathology | February 12, 2018 | Volume: 29 | Issue: 5_ts | Pages: 496-502

10.1093/ajcp/29.5_ts.496 | PMID 13533354 Get It

Enterococcus faecalis Sex Pheromone cCF10 Enhances Conjugative Plasmid Transfer In Vivo
Hirt, Helmut, Greenwood‐Quaintance, Kerryl E. , Karau, Melissa J. , Till, Lisa , Kashyap, Purna , Patel, Robin , Dunny, Gary M. , Till, Lisa M, Patel, Robin

Mayo Clinic

mBio | February 12, 2018 | Volume: 9 | Issue: 1 | Pages: No page available

10.1128/mbio.00037-18 | PMID 29440568 Get It

ABSTRACT Cell-cell communication mediated by peptide pheromones (cCF10 [CF]) is essential for high-frequency plasmid transfer in vitro in Enterococcus faecalis . To examine the role of pheromone signaling in vivo , we established either a CF-producing (CF+) recipient or a recipient producing a biologically inactive variant of CF (CF− recipient) in a germfree mouse model 3 days before donor inoculation and determined transfer frequencies of the pheromone-inducible plasmid pCF10. Plasmid transfer was detected in the upper and middle sections of the intestinal tract 5 h after donor inoculation and was highly efficient in the absence of antibiotic selection. The transconjugant/donor ratio reached a maximum level approaching 1 on day 4 in the upper intestinal tract. Plasmid transfer was significantly lower with the CF− recipient. While rescue of the CF− mating defect by coculture with CF+ recipients is easily accomplished in vitro , no extracellular complementation occurred in vivo . This suggests that most pheromone signaling in the gut occurs between recipient and donor cells in very close proximity. Plasmid-bearing cells (donors plus transconjugants) steadily increased in the population from 0.1% after donor inoculation to about 10% at the conclusion of the experiments. This suggests a selective advantage of pCF10 carriage distinct from antibiotic resistance or bacteriocin production. Our results demonstrate that pheromone signaling is required for efficient pCF10 transfer in vivo . In the absence of CF+ recipients, a low level of transfer to CF− recipients occurred in the gut. This may result from low-level host-mediated induction of the donors in the gastrointestinal (GI) tract, similar to that previously observed in serum. IMPORTANCE Horizontal gene transfer is a major factor in the biology of Enterococcus faecalis , an important nosocomial pathogen. Previous studies showing efficient conjugative plasmid transfer in the gastrointestinal (GI) tracts of experimental animals did not examine how the enterococcal sex pheromone response impacts the efficiency of transfer. Our study demonstrates for the first time pheromone-enhanced, high-frequency plasmid transfer of E. faecalis plasmid pCF10 in a mouse model in the absence of antibiotic or bacteriocin selection. Pheromone production by recipients dramatically increased plasmid transfer in germfree mice colonized initially with recipients, followed by donors. The presence of a coresident community of common gut microbes did not significantly reduce in vivo plasmid transfer between enterococcal donors and recipients. In mice colonized with enterococcal recipients, we detected plasmid transfer in the intestinal tract within 5 h of addition of donors, before transconjugants could be cultured from feces. Surprisingly, pCF10 carriage provided a competitive fitness advantage unrelated to antibiotic resistance or bacteriocin production.
Method for Staining Neurons, Axons, and Boutons Terminaux in Paraffin Sections
Schmit, Robert W.

Mayo Clinic

American Journal of Clinical Pathology | February 12, 2018 | Volume: 28 | Issue: 1_ts | Pages: 107-110

10.1093/ajcp/28.1_ts.107 | PMID 13458133 Get It

Use of a Selective Medium for Isolation of Brucella from Contaminated Surgical Specimens
Weed, Lyle A.

Mayo Clinic

American Journal of Clinical Pathology | February 12, 2018 | Volume: 27 | Issue: 4_ts | Pages: 482-485

10.1093/ajcp/27.4_ts.482 | PMID 13424499 Get It

A Hydrometer for Quick and Accurate Determination of Specific Gravity in Urine
Magath, Thomas B.

Mayo Clinic

American Journal of Clinical Pathology | February 12, 2018 | Volume: 25 | Issue: 10_ts | Pages: 1217-1219

10.1093/ajcp/25.10_ts.1217 | PMID 13258534 Get It

Fresh-Frozen Sections—their Permanent Preservation
Dockerty, Malcolm B., Jackson, Richard L.

Mayo Clinic

American Journal of Clinical Pathology | February 12, 2018 | Volume: 25 | Issue: 11_ts | Pages: 1331-1332

10.1093/ajcp/25.11_ts.1331 | PMID 13268361 Get It

The problems facing academic surgeons
Khalpey, Zain

Mayo Clinic

BMJ | February 12, 2018 | Volume: 328 | Issue: 7437 | Pages: s78.1-s78

10.1136/bmj.328.7437.s78 Get It

A Practical Review of the Emerging Direct Anticoagulants, Laboratory Monitoring, and Reversal Agents
Joppa, Stephanie, Adamski, Jill , Patel, Salma , Al‐Saffar, Farah , Esser, Heidi, Shamoun, Fadi , Joppa, Stephanie A, Wysokinski, Waldemar, Al-Saffar, Farah, Salciccioli, Justin D. , Wysokiński, Waldemar E. , McBane, Robert D.

Mayo Clinic

Journal of Clinical Medicine | February 12, 2018 | Volume: 7 | Issue: 2 | Pages: 29

10.3390/jcm7020029 | PMID 29439477 Get It

Millions of patients in the United States use anticoagulation for a variety of indications, such as the prevention of stroke in those with atrial fibrillation (AF) and the treatment and prevention of venous thrombosis. For over six decades warfarin was the only available oral anticoagulant, but now several DOACs are available and their use has become more prevalent in recent years. In spite of this increased use, many physicians remain reluctant to prescribe DOACs due to concerns about bleeding and reversibility.